Renew Biopharma Announces Licensing Agreement with Hypercann Agrogenetics to Employ Proprietary Enzymes for Improved Varieties of Hemp

Renew Biopharma Inc., a preclinical drug discovery company, today announced a licensing agreement with Hypercann Agrogenetics Inc. giving Hypercann rights to use Renews proprietary engineered enzymes to modify Cannabis plants for improved profiles of cannabinoids.